Dolby Laboratories (NYSE:DLB) Reaches New 12-Month Low – Here’s What Happened

Dolby Laboratories (NYSE:DLB) reached a new 52-week low during mid-day trading on Tuesday . The stock traded as low as $48.62 and last traded at $48.7080, with a volume of 16058 shares trading hands. The stock had previously closed at $49.36.

Analysts Set New Price Targets

A number of research firms have recently commented on DLB. Wall Street Zen upgraded Dolby Laboratories from a “hold” rating to a “buy” rating in a research report on Saturday, May 30th. Rosenblatt Securities restated a “buy” rating and set a $85.00 price target on shares of Dolby Laboratories in a research note on Thursday, June 11th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Dolby Laboratories in a research report on Wednesday, June 24th. Finally, Barrington Research reiterated an “outperform” rating and issued a $90.00 price objective on shares of Dolby Laboratories in a research note on Monday, June 15th. Three equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. Based on data from MarketBeat, Dolby Laboratories has a consensus rating of “Moderate Buy” and an average target price of $90.75.

Dolby Laboratories Stock Performance

The company has a market cap of $4.65 billion, a PE ratio of 19.43 and a beta of 0.81. The stock’s 50-day simple moving average is $53.25 and its 200 day simple moving average is $59.66.

Dolby Laboratories (NYSE:DLB) last released its earnings results on Thursday, April 30th. The electronics maker reported $1.37 EPS for the quarter, topping the consensus estimate of $1.31 by $0.06. Dolby Laboratories had a net margin of 17.85% and a return on equity of 11.47%. The company had revenue of $395.63 million during the quarter, compared to analysts’ expectations of $385.80 million. During the same quarter last year, the business earned $1.34 EPS. The business’s revenue was up 7.0% on a year-over-year basis. Dolby Laboratories has set its FY 2026 guidance at 4.300-4.450 EPS and its Q3 2026 guidance at 0.560-0.710 EPS. On average, sell-side analysts predict that Dolby Laboratories will post 3.21 EPS for the current fiscal year.

Dolby Laboratories Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, May 20th. Shareholders of record on Tuesday, May 12th were issued a $0.36 dividend. This represents a $1.44 dividend on an annualized basis and a yield of 2.9%. The ex-dividend date of this dividend was Tuesday, May 12th. Dolby Laboratories’s payout ratio is currently 56.92%.

Insiders Place Their Bets

In related news, CFO Robert J. Park sold 4,895 shares of Dolby Laboratories stock in a transaction that occurred on Tuesday, May 12th. The stock was sold at an average price of $56.68, for a total value of $277,448.60. Following the sale, the chief financial officer directly owned 81,490 shares in the company, valued at $4,618,853.20. The trade was a 5.67% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, SVP John D. Couling sold 7,667 shares of the company’s stock in a transaction on Wednesday, July 1st. The stock was sold at an average price of $53.20, for a total value of $407,884.40. Following the transaction, the senior vice president directly owned 118,727 shares in the company, valued at $6,316,276.40. This represents a 6.07% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last 90 days, insiders have sold 47,458 shares of company stock worth $2,639,537. Company insiders own 37.93% of the company’s stock.

Institutional Investors Weigh In On Dolby Laboratories

Institutional investors have recently made changes to their positions in the stock. Norges Bank purchased a new position in shares of Dolby Laboratories in the 4th quarter valued at about $54,966,000. AQR Capital Management LLC boosted its holdings in Dolby Laboratories by 51.8% during the second quarter. AQR Capital Management LLC now owns 1,736,260 shares of the electronics maker’s stock worth $128,935,000 after buying an additional 592,282 shares in the last quarter. First Trust Advisors LP boosted its holdings in Dolby Laboratories by 19.9% during the first quarter. First Trust Advisors LP now owns 2,254,933 shares of the electronics maker’s stock worth $135,431,000 after buying an additional 374,405 shares in the last quarter. Alyeska Investment Group L.P. acquired a new position in Dolby Laboratories during the fourth quarter worth about $23,477,000. Finally, Voloridge Investment Management LLC grew its position in Dolby Laboratories by 2,017.9% during the fourth quarter. Voloridge Investment Management LLC now owns 325,499 shares of the electronics maker’s stock worth $20,904,000 after buying an additional 310,130 shares during the period. 58.56% of the stock is currently owned by hedge funds and other institutional investors.

Dolby Laboratories Company Profile

Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.

Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.